Medigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement Post author:GHIAA Admin Post published:October 10, 2023 Post category: Continue ReadingMedigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement
University of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement Post author:GHIAA Admin Post published:September 25, 2023 Post category: Continue ReadingUniversity of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement
CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement Post author:GHIAA Admin Post published:September 18, 2023 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement Post author:GHIAA Admin Post published:September 18, 2023 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement Post author:GHIAA Admin Post published:September 18, 2023 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement Post author:GHIAA Admin Post published:September 18, 2023 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:December 15, 2022 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
Shionogi – GARDP, Cefiderocol License Agreement Post author:GHIAA Admin Post published:July 8, 2022 Post category: Continue ReadingShionogi – GARDP, Cefiderocol License Agreement
Shionogi – GARDP, Cefiderocol License Agreement Post author:GHIAA Admin Post published:July 8, 2022 Post category: Continue ReadingShionogi – GARDP, Cefiderocol License Agreement